Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Short- and Long-Term Safety of S53P4 Bioactive Glass for Mastoid Obliteration: a Retrospective Comparative Study

NCT06160388 is registered in ClinicalTrials.gov with Diakonessenhuis, Utrecht as lead sponsor.

NCT NCT06160388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06160388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Short- and Long-Term Safety of S53P4 Bioactive Glass for Mastoid Obliteration: a Retrospective Comparative Study
Lead sponsor
Diakonessenhuis, Utrecht
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
March 1, 2025
Enrollment
1,196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mastoid cavity